New Co-Editor-in-Chief Appointed
Lorraine V. Kalia, MD, PhD, FRCPC, an Associate Professor and Clinician Scientist in the Division of Neurology at the University of Toronto and a Senior Scientist at the Krembil Research Institute of the University Health Network, joins JPD! Click for details.

New Blog Written by Sharon Krischer
Going to the World Parkinson Congress for the first time can be an exciting challenge for a person with Parkinson’s disease. On the one hand, there is so much to see and do it is almost like a Disneyland for People with Parkinson’s. On the other hand, how do you fit everything into 3,5 days? Somehow, executive director Elizabeth (Eli) Pollard and her team managed to bring together an amazing international conference that is inspiring, educational and welcoming to all in the Parkinson’s community.

New Blog Written by Frank C. Church, PhD
Cure Parkinson's (CP) started the international Linked Clinical Trials (iLCT) initiative to repurpose drugs for the treatment of Parkinson's disease (PD). Combining priorities with the Van Andel Institute (VAI), they hold an annual two-day meeting to present, examine, discuss, and prioritize suitable compounds for streamlining into clinical trials specifically for slowing down/stopping/reversing the progression of PD.

New Patient’s Perspective Written by Sharon Chakkalackal
"This is my journey of how I came to be diagnosed with Young Onset Parkinson’s Disorder (YOPD) symptoms at the age of 38."